Jeffrey J. Brown - Aug 8, 2022 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Stock symbol
MED
Transactions as of
Aug 8, 2022
Transactions value $
$59,538
Form type
4
Date filed
8/10/2022, 06:01 PM
Previous filing
Jul 14, 2022
Next filing
Aug 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Award $1.25K +9.04 +0.39% $138.78 2.35K Aug 8, 2022 Direct F1
transaction MED Common Stock Purchase $58.3K +399 +1.12% $146.01 35.9K Aug 4, 2022 Brown Equity Partners, LLC F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.
F2 The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member, pursuant to a broker-sponsored Dividend Reinvestment Plan.
F3 These shares are directly owned by Brown Equity Partners, LLC, for which the reporting persons is the managing member.